FunPep Company Limited (4881.T)
JPY 131.0
(0.77%)
JPY 131.0
(0.77%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -933.41 Million JPY | 20.39% |
| 2022 | -1.17 Billion JPY | -71.86% |
| 2021 | -682.26 Million JPY | -34.32% |
| 2020 | -507.93 Million JPY | -115.97% |
| 2019 | -235.18 Million JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -168.54 Million JPY | 9.84% |
| 2024 Q2 | -210.8 Million JPY | -25.07% |
| 2023 Q2 | -243.91 Million JPY | 28.59% |
| 2023 Q4 | -186.94 Million JPY | -16.12% |
| 2023 Q1 | -341.56 Million JPY | 3.2% |
| 2023 FY | -933.41 Million JPY | 20.39% |
| 2023 Q3 | -160.99 Million JPY | 34.0% |
| 2022 Q3 | -298.13 Million JPY | 0.0% |
| 2022 FY | -1.17 Billion JPY | -71.86% |
| 2022 Q4 | -352.84 Million JPY | -18.35% |
| 2021 FY | -682.26 Million JPY | -34.32% |
| 2020 FY | -507.93 Million JPY | -115.97% |
| 2019 FY | -235.18 Million JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 384 Million JPY | 343.077% |
| PRISM BioLab Co.,LTD | -526.91 Million JPY | -77.148% |
| GNI Group Ltd. | 8.09 Billion JPY | 111.532% |
| Linical Co., Ltd. | 338.26 Million JPY | 375.941% |
| Trans Genic Inc. | 4.08 Million JPY | 22949.841% |
| MEDINET Co., Ltd. | -1.43 Billion JPY | 35.087% |
| Soiken Holdings Inc. | -662.2 Million JPY | -40.956% |
| Cytori Cell Research Institute, Inc. | 138.15 Million JPY | 775.63% |
| AnGes, Inc. | -7.43 Billion JPY | 87.45% |
| OncoTherapy Science, Inc. | -1.28 Billion JPY | 27.538% |
| Nxera Pharma Co., Ltd. | -7.19 Billion JPY | 87.023% |
| Immuno-Biological Laboratories Co., Ltd. | 186.69 Million JPY | 599.971% |
| NanoCarrier Co., Ltd. | -780 Million JPY | -19.668% |
| Carna Biosciences, Inc. | -1.15 Billion JPY | 19.037% |
| CanBas Co., Ltd. | -1.2 Billion JPY | 22.794% |
| D. Western Therapeutics Institute, Inc. | -812.41 Million JPY | -14.895% |
| RaQualia Pharma Inc. | -323.66 Million JPY | -188.392% |
| Chiome Bioscience Inc. | -1.22 Billion JPY | 23.492% |
| Kidswell Bio Corporation | -1.42 Billion JPY | 34.363% |
| PeptiDream Inc. | 3.03 Billion JPY | 130.747% |
| Oncolys BioPharma Inc. | -1.93 Billion JPY | 51.849% |
| Ribomic Inc. | -1.02 Billion JPY | 8.867% |
| SanBio Company Limited | -2.64 Billion JPY | 64.697% |
| Healios K.K. | -3.82 Billion JPY | 75.584% |
| BrightPath Biotherapeutics Co., Ltd. | -1.16 Billion JPY | 20.09% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.48 Billion JPY | 37.338% |
| Delta-Fly Pharma, Inc. | -1.42 Billion JPY | 34.698% |
| StemRIM | -2.02 Billion JPY | 53.837% |
| CellSource Co., Ltd. | 923.14 Million JPY | 201.113% |
| Kringle Pharma, Inc. | -854.15 Million JPY | -9.28% |
| Stella Pharma Corporation | -763.74 Million JPY | -22.215% |
| TMS Co., Ltd. | -960.04 Million JPY | 2.773% |
| Noile-Immune Biotech Inc. | -1.13 Billion JPY | 17.398% |
| Cuorips Inc. | -632.18 Million JPY | -47.65% |
| K Pharma,Inc. | 260.33 Million JPY | 458.551% |
| Takara Bio Inc. | 1.48 Billion JPY | 163.069% |
| ReproCELL Incorporated | -31.41 Million JPY | -2871.243% |
| PhoenixBio Co., Ltd. | 26.37 Million JPY | 3638.616% |
| StemCell Institute Inc. | 310.98 Million JPY | 400.152% |
| Japan Tissue Engineering Co., Ltd. | 143.16 Million JPY | 751.968% |
| CellSeed Inc. | -846.53 Million JPY | -10.263% |